1. Home
  2. FLGT vs FTHY Comparison

FLGT vs FTHY Comparison

Compare FLGT & FTHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • FTHY
  • Stock Information
  • Founded
  • FLGT 2011
  • FTHY 2020
  • Country
  • FLGT United States
  • FTHY United States
  • Employees
  • FLGT N/A
  • FTHY N/A
  • Industry
  • FLGT Medical Specialities
  • FTHY Investment Managers
  • Sector
  • FLGT Health Care
  • FTHY Finance
  • Exchange
  • FLGT Nasdaq
  • FTHY Nasdaq
  • Market Cap
  • FLGT 508.7M
  • FTHY 533.6M
  • IPO Year
  • FLGT 2016
  • FTHY N/A
  • Fundamental
  • Price
  • FLGT $16.46
  • FTHY $14.57
  • Analyst Decision
  • FLGT Hold
  • FTHY
  • Analyst Count
  • FLGT 1
  • FTHY 0
  • Target Price
  • FLGT $22.00
  • FTHY N/A
  • AVG Volume (30 Days)
  • FLGT 225.7K
  • FTHY 176.7K
  • Earning Date
  • FLGT 02-28-2025
  • FTHY 01-01-0001
  • Dividend Yield
  • FLGT N/A
  • FTHY 10.93%
  • EPS Growth
  • FLGT N/A
  • FTHY N/A
  • EPS
  • FLGT N/A
  • FTHY N/A
  • Revenue
  • FLGT $277,761,000.00
  • FTHY N/A
  • Revenue This Year
  • FLGT N/A
  • FTHY N/A
  • Revenue Next Year
  • FLGT $16.00
  • FTHY N/A
  • P/E Ratio
  • FLGT N/A
  • FTHY N/A
  • Revenue Growth
  • FLGT N/A
  • FTHY N/A
  • 52 Week Low
  • FLGT $15.99
  • FTHY $12.66
  • 52 Week High
  • FLGT $25.50
  • FTHY $14.74
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 42.71
  • FTHY 48.15
  • Support Level
  • FLGT $16.47
  • FTHY $14.47
  • Resistance Level
  • FLGT $17.39
  • FTHY $14.62
  • Average True Range (ATR)
  • FLGT 0.54
  • FTHY 0.10
  • MACD
  • FLGT 0.10
  • FTHY -0.01
  • Stochastic Oscillator
  • FLGT 33.57
  • FTHY 35.71

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About FTHY First Trust High Yield Opportunities 2027 Term Fund

FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income.

Share on Social Networks: